Cargando…
Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
Hepatocellular carcinoma (HCC) is one of the deadliest and most common malignancies of the liver. Considering the rich immune background of carcinogenesis in HCC, efforts have been focused on further understanding the role of the immune system in tumor suppression and promotion. The utilization of i...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244992/ https://www.ncbi.nlm.nih.gov/pubmed/35949209 http://dx.doi.org/10.4251/wjgo.v14.i6.1210 |